Acadia Healthcare Company (ACHC) 44th Annual J.P. Morgan Healthcare Conference summary

Company Overview and Strategic Vision

• Operates 277 facilities across 40 states and Puerto Rico, serving over 82,000 patients daily across four service lines.

• Maintains strong diversification by service line, payer mix (over half revenue from Medicaid), and geography.

• Strategic vision centers on high-quality, evidence-based care, expanding access, workforce development, and technology leadership.

• Partnerships with 21 leading health systems through joint ventures, with repeat partners in new geographies, help address unmet needs and free capacity for medical patients.

• Technology investments include EMRs, remote monitoring, analytics, and operational effectiveness initiatives.

Operational Progress and Quality Initiatives

• Achieved six consecutive quarters of improved staff retention through wage management, recruitment, and training, with leadership transformation enhancing clinical progress.

• Opened six new facilities in 2025, adding 1,089 beds, while five facilities closed, reducing 382 beds; over 1,000 new beds opened in 2025 and more than 2,500 beds added from new facilities in the past year.

• Significant investments in care and technology led to improved patient outcomes, safety, and experience, with strong KPI performance.

• CTC clinics reduced wait times to five minutes or less, achieving 99%+ quality scores and >50% of patients opioid-free at six months.

• Ongoing focus on operational improvements includes facility turnarounds, workforce strengthening, and payor relationship enhancements.

Financial Performance and Growth Drivers

• 2025 guidance reiterated: revenue $3.28–$3.3B, adjusted EBITDA $601–$611M, adjusted EPS $1.94–$2.04.

• Trailing twelve months revenue through 9/30/2025 reached $3.3B.

• Over $200M incremental EBITDA opportunity projected from new facility openings and ramping beds, with 500–700 more beds expected in 2026, representing $150M+ future EBITDA at maturity.

• CapEx to decline by at least $300M in 2026, enabling positive free cash flow and further reductions in 2027.

• 2025 financials impacted by higher professional liability costs, Medicaid volume softness, payer pressure, and regulatory and credentialing delays.